Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 60

Results For "Vaccines"

748 News Found

UAE authorises Sputnik Light vaccine as universal booster
News | November 30, 2021

UAE authorises Sputnik Light vaccine as universal booster

Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE


Thermo Fisher Scientific confirms its TaqParth Covid-19 kit can detect Omicron
Medical Device | November 29, 2021

Thermo Fisher Scientific confirms its TaqParth Covid-19 kit can detect Omicron

The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone


Bharat Biotech commences export of Covaxin
News | November 29, 2021

Bharat Biotech commences export of Covaxin

It’s a two-dose vaccine administered 28 days apart


Pharma firms switch to advanced pharma manufacturing
Supply Chain | November 27, 2021

Pharma firms switch to advanced pharma manufacturing

Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies


Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron
Biotech | November 26, 2021

Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron

The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease


GreenLight Biosciences and Samsung Biologics to build vaccine capacity
Biotech | November 25, 2021

GreenLight Biosciences and Samsung Biologics to build vaccine capacity

The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate


Sputnik Light in India by December: RDIF
News | November 25, 2021

Sputnik Light in India by December: RDIF

One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster


Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D
News | November 25, 2021

Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D

The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022


Bharat Biotech updates on the Lancet study on Covaxin efficacy
News | November 25, 2021

Bharat Biotech updates on the Lancet study on Covaxin efficacy

An effectiveness result of 50 per cent achieved during the peak delta variant Covid-19 wave in India, in a highrisk study population of physicians and healthcare workers, in a hospital environment, provides insights into the efficacy and effectiveness of Covaxin


Serum Life Sciences invests US $ 10 million in GreenLight Biosciences
Biotech | November 24, 2021

Serum Life Sciences invests US $ 10 million in GreenLight Biosciences

GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible